project id: TCGA-HNSC; case submitter id: TCGA-CR-7399; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 9.3; age at index: 60; days to birth: -22182; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1948; age at diagnosis: 22182; ajcc clinical m: M0; ajcc clinical n: N2c; ajcc clinical stage: Stage IVA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N2c; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 181.0; icd 10 code: C32.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Larynx, NOS; synchronous malignancy: No; tissue or organ of origin: Larynx, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 7.397260273972603; pack years smoked: 135.0; is ffpe: false; composition: Not Reported; intermediate dimension: 0.0; longest dimension: 0.1; preservation method: Unknown; shortest dimension: 0.0; sample id: 05c3d8a0-47a2-44b2-b0c3-144ec0cb2673; sample submitter id: TCGA-CR-7399-01A; portion id: 61a9b072-6c25-4e66-b406-9b68a90d05bc; portion submitter id: TCGA-CR-7399-01A-11; slide id: b87c5422-1239-4ffd-ba83-5969e2c2d9ce; slide submitter id: TCGA-CR-7399-01A-01-TS1; percent lymphocyte infiltration: 25.0; percent monocyte infiltration: 0.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 98.0; percent tumor nuclei: 65.0; section location: TOP;